Innovative Cancer Treatment Targets Protein Interactions to Halt Tumor Growth
Scientists have developed a targeted cancer therapy that inhibits the interaction between the RAS gene and a key pathway, successfully stopping tumor growth in mice without harming healthy cells, and it is now entering human clinical trials.